Related Experiment Videos
Regional citrate anticoagulation in critically ill patients treated with plasma filtration and adsorption
Filippo Mariano1, Ciro Tetta, Maurizio Stella
1Department of Medical Area, Nephrology and Dialysis Unit, CTO Hospital, Turin, Italy. dialisi@cto.to.it
Background:
In high-risk bleeding conditions conventional systemic anticoagulation with heparin is a contraindication to renal replacement therapy. We evaluate the feasibility and safety of regional citrate anticoagulation in high-risk bleeding conditions during coupled plasma filtration adsorption (CPFA).
Methods:
Thirteen critically ill patients (9 severely burned, 4 polytraumas) with septic shock and acute renal failure treated with CPFA-CVVHD by using bicarbonate-based solutions (heparin-CPFA group, 58 sessions) or with CPFA-CVVHF using citrate (citrate-CPFA group, 36 sessions).
Results:
Plasma flow and used cartridges showed no differences between the citrate-CPFA and heparin-CPFA groups, while lost clotted cartridges were significantly lower in the citrate-CPFA group. Blood ionized calcium (iCa2+), Ca2+ infusion, pH and bicarbonates remained constant during citrate-CPFA, with no difference between pre- and post-cartridge plasma citrate. A significant positive correlation between iCa2+ in blood and ultrafiltrate was present.
Conclusions:
These suits demonstrate the feasibility and safety of regional citrate anticoagulation in severely burned and polytrauma septic patients treated by CPFA.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Venous Thrombosis III: Interprofessional Care
Continuous Renal Replacement Therapy
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins